UK markets closed

Sangamo Therapeutics, Inc. (SGMO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.6702+0.0455 (+7.28%)
At close: 04:00PM EDT
0.6450 -0.03 (-3.76%)
After hours: 07:59PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
176,232
176,232
111,299
110,701
118,192
Operating expenses
Research development
234,057
234,057
249,898
230,819
180,647
Selling general and administrative
61,167
61,167
62,682
63,219
67,097
Total operating expenses
295,224
295,224
312,580
294,038
247,744
Operating income or loss
-118,992
-118,992
-201,281
-183,337
-129,552
Total other income/expenses net
-155,013
-155,013
-
-
-
Income before tax
-262,903
-262,903
-191,849
-177,991
-120,777
Income tax expense
-5,072
-5,072
429
306
345
Income from continuing operations
-257,831
-257,831
-192,278
-178,297
-121,122
Net income
-257,831
-257,831
-192,278
-178,286
-120,996
Net income available to common shareholders
-257,831
-257,831
-192,278
-178,286
-120,996
Basic EPS
-1.25
-1.48
-1.25
-1.23
-0.90
Diluted EPS
-1.25
-1.48
-1.25
-1.23
-0.90
Basic average shares
154,345
174,444
154,345
144,568
134,449
Diluted average shares
154,345
174,444
154,345
144,568
134,449